February 2006 PDF Print E-mail
Schaapveld M, de Vries EG, van der Graaf WT, Otter R, de Vries J, Willemse PH.  
The Prognostic Effect of the Number of Histologically Examined Axillary Lymph Nodes in Breast Cancer: Stage Migration or Age Association?
Ann Surg Oncol. 2006 Feb 20;
Grunfeld E, Levine MN, Julian JA, Coyle D, Szechtman B, Mirsky D, Verma S, Dent S, Sawka C, Pritchard KI, Ginsburg D, Wood M, Whelan T.  
Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care.
J Clin Oncol. 2006 Feb 20;24(6):848-55.
Redston M, Compton CC, Miedema BW, Niedzwiecki D, Dowell JM, Jewell SD, Fleshman JM, Bem J, Mayer RJ, Bertagnolli MM.  
Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: results of cancer and leukemia group B trial 80001.
J Clin Oncol. 2006 Feb 20;24(6):878-83.
Westphal M, Ram Z, Riddle V, Hilt D, Bortey E; On behalf of the Executive Committee of the Gliadel(R) Study Group.  
Gliadel((R)) wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial.
Acta Neurochir (Wien). 2006 Feb 17;
van Rijk MC, Nieweg OE, Rutgers EJ, Oldenburg HS, Olmos RV, Hoefnagel CA, Kroon BB.  
Sentinel Node Biopsy Before Neoadjuvant Chemotherapy Spares Breast Cancer Patients Axillary Lymph Node Dissection.
Ann Surg Oncol. 2006 Feb 17;
Goldenberg D, Sciubba J, Koch WM.  
Cystic metastasis from head and neck squamous cell cancer: A distinct disease variant?
Head Neck. 2006 Feb 13;
McMillan AS, Pow EH, Kwong DL, Wong MC, Sham JS, Leung LH, Leung WK.  
Preservation of quality of life after intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: Results of a prospective longitudinal study.
Head Neck. 2006 Feb 10;
Koukourakis MI, Bentzen SM, Giatromanolaki A, Wilson GD, Daley FM, Saunders MI, Dische S, Sivridis E, Harris AL.  
Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial.
J Clin Oncol. 2006 Feb 10;24(5):727-35.
Bajetta E, Del Vecchio M, Nova P, Fusi A, Daponte A, Sertoli MR, Queirolo P, Taveggia P, Bernengo MG, Legha SS, Formisano B, Cascinelli N.  
Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-{alpha}2b in metastatic melanoma.
Ann Oncol. 2006 Feb 9;
Stafinski T, Jhangri GS, Yan E, Menon D.  
Effectiveness of stereotactic radiosurgery alone or in combination with whole brain radiotherapy compared to conventional surgery and/or whole brain radiotherapy for the treatment of one or more brain metastases: A systematic review and meta-analysis.
Cancer Treat Rev. 2006 Feb 9;
Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK.  
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.
N Engl J Med. 2006 Feb 9;354(6):567-78.
Kreth FW, Faist M, Grau S, Ostertag CB.  
Interstitial (125)I radiosurgery of supratentorial de novo WHO Grade 2 astrocytoma and oligoastrocytoma in adults: long-term results and prognostic factors.
Cancer. 2006 Feb 8;
Ortholan C, Francois E, Thomas O, Benchimol D, Baulieux J, Bosset JF, Gerard JP.  
Role of Radiotherapy With Surgery for T3 and Resectable T4 Rectal Cancer: Evidence From Randomized Trials.
Dis Colon Rectum. 2006 Feb 6;
Mangar S, Slevin N, Mais K, Sykes A.  
Evaluating predictive factors for determining enteral nutrition in patients receiving radical radiotherapy for head and neck cancer: A retrospective review.
Radiother Oncol. 2006 Feb 5;
Perry A, Schmidt RE.  
Cancer therapy-associated CNS neuropathology: an update and review of the literature.
Acta Neuropathol (Berl). 2006 Feb 4;:1-16
Combs SE, Thilmann C, Debus J, Schulz-Ertner D.  
Long-term outcome of stereotactic radiosurgery (SRS) in patients with acoustic neuromas.
Int J Radiat Oncol Biol Phys. 2006 Feb 4;
Freedman GM, Anderson PR, Li J, Eisenberg DF, Hanlon AL, Wang L, Nicolaou N.  
Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer.
Am J Clin Oncol. 2006 Feb;29(1):66-70.
Brown P, Clark MM, Atherton P, Huschka M, Sloan JA, Gamble G, Girardi J, Frost MH, Piderman K, Rummans TA.  
Will improvement in quality of life (QOL) impact fatigue in patients receiving radiation therapy for advanced cancer?
Am J Clin Oncol. 2006 Feb;29(1):52-8.
Mendenhall WM, Morris CG, Amdur RJ, Hinerman RW, Werning JW, Villaret DB.  
Definitive radiotherapy for squamous cell carcinoma of the base of tongue.
Am J Clin Oncol. 2006 Feb;29(1):32-9.
Bastasch MD, Teh BS, Mai WY, McGary JE, Grant WH 3rd, Butler EB.  
Tolerance of endorectal balloon in 396 patients treated with intensity-modulated radiation therapy (IMRT) for prostate cancer.
Am J Clin Oncol. 2006 Feb;29(1):8-11.
Vaquerano J, Kraybill WG, Driscoll DL, Cheney R, Kane JM 3rd.  
American joint committee on cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma.
Ann Surg Oncol. 2006 Feb;13(2):198-204.
Regel JP, Schoch B, Sandalcioglu IE, Wieland R, Westermeier C, Stolke D, Wiedemayer H.  
Malignant meningioma as a second malignancy after therapy for acute lymphatic leukemia without cranial radiation.
Childs Nerv Syst. 2006 Feb;22(2):172-5.
Incrocci L.  
Sexual function after external-beam radiotherapy for prostate cancer: What do we know?
Crit Rev Oncol Hematol. 2006 Feb;57(2):165-73.
Tateya I, Hirano S, Kojima H, Omori K, Shoji K, Mitsumori M, Nagata Y, Ito J.  
Hyperfractionated radiotherapy for T2 glottic cancer for preservation of the larynx.
Eur Arch Otorhinolaryngol. 2006 Feb;263(2):144-8.
Truong PT, Woodward WA, Buchholz TA.  
Optimizing locoregional control and survival for women with breast cancer: a review of current developments in postmastectomy radiotherapy.
Expert Rev Anticancer Ther. 2006 Feb;6(2):205-16.
Ansarin M, Zabrodsky M, Bianchi L, Renne G, Tosoni A, Calabrese L, Tredici P, Jereczek-Fossa BA, Orecchia R, Chiesa F.  
Endoscopic CO2 laser surgery for early glottic cancer in patients who are candidates for radiotherapy: results of a prospective nonrandomized study.
Head Neck. 2006 Feb;28(2):121-5.
Tham IW, Lee KM, Yap SP, Loong SL.  
Outcome of patients with nasal natural killer (NK)/T-cell lymphoma treated with radiotherapy, with or without chemotherapy.
Head Neck. 2006 Feb;28(2):126-34.
Pellitteri PK, Ferlito A, Rinaldo A, Shah JP, Weber RS, Lowry J, Medina JE, Gourin CG, Robbins KT, Suarez C, Shaha AR, Genden EM, Leemans CR, Lefebvre JL, Kowalski LP, Wei WI.  
Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all?
Head Neck. 2006 Feb;28(2):166-75.
Massager N, Nissim O, Delbrouck C, Devriendt D, David P, Desmedt F, Wikler D, Hassid S, Brotchi J, Levivier M.  
Role of intracanalicular volumetric and dosimetric parameters on hearing preservation after vestibular schwannoma radiosurgery.
Int J Radiat Oncol Biol Phys. 2006 Feb 1;
van Tol-Geerdink JJ, Stalmeier PF, Pasker-de Jong PC, Huizenga H, van Lin EN, Schimmel EC, Leer JW, van Daal WA.  
Systematic review of the effect of radiation dose on tumor control and morbidity in the treatment of prostate cancer by 3D-CRT.
Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):534-43.
Korytko T, Radivoyevitch T, Colussi V, Wessels BW, Pillai K, Maciunas RJ, Einstein DB.  
12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors.
Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):419-24.
Basaki K, Abe Y, Aoki M, Kondo H, Hatayama Y, Nakaji S.  
Prognostic factors for survival in stage III non-small-cell lung cancer treated with definitive radiation therapy: Impact of tumor volume.
Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):449-54.
Czito BG, Willett CG, Bendell JC, Morse MA, Tyler DS, Fernando NH, Mantyh CR, Blobe GC, Honeycutt W, Yu D, Clary BM, Pappas TN, Ludwig KA, Hurwitz HI.  
Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results.
J Clin Oncol. 2006 Feb 1;24(4):656-62.
Rummans TA, Clark MM, Sloan JA, Frost MH, Bostwick JM, Atherton PJ, Johnson ME, Gamble G, Richardson J, Brown P, Martensen J, Miller J, Piderman K, Huschka M, Girardi J, Hanson J.  
Impacting quality of life for patients with advanced cancer with a structured multidisciplinary intervention: a randomized controlled trial.
J Clin Oncol. 2006 Feb 1;24(4):635-42.
Koontz BF, Kirkpatrick JP, Clough RW, Prosnitz RG, Gockerman JP, Moore JO, Prosnitz LR.  
Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications.
J Clin Oncol. 2006 Feb 1;24(4):605-11.
Barakat RR, Bundy BN, Spirtos NM, Bell J, Mannel RS; Gynecologic Oncology Group Study.  
Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study.
J Clin Oncol. 2006 Feb 1;24(4):587-92.
Kim JS, Kim JS, Cho MJ, Yoon WH, Song KS.  
Comparison of the Efficacy of Oral Capecitabine versus Bolus 5-FU in Preoperative Radiotherapy of Locally Advanced Rectal Cancer.
J Korean Med Sci. 2006 Feb;21(1):52-7.
Christopoulou A, Retsas S, Kingsley D, Paddick I, Lindquist C.  
Integration of gamma knife surgery in the management of cerebral metastases from melanoma.
Melanoma Res. 2006 Feb;16(1):51-7.
Wanebo JE, Bristol RE, Porter RR, Coons SW, Spetzler RF.  
Management of cranial base chondrosarcomas.
Neurosurgery. 2006 Feb;58(2):249-55; discussion 249-55.
Pollock BE.  
Management of vestibular schwannomas that enlarge after stereotactic radiosurgery: treatment recommendations based on a 15 year experience.
Neurosurgery. 2006 Feb;58(2):241-8; discussion 241-8.
Lee DJ, Maseyesva B, Westra W, Long D, Niparko JK, Califano J.  
Microsatellite analysis of recurrent vestibular schwannoma (acoustic neuroma) following stereotactic radiosurgery.
Otol Neurotol. 2006 Feb;27(2):213-9.
Ascherman JA, Hanasono MM, Newman MI, Hughes DB.  
Implant reconstruction in breast cancer patients treated with radiation therapy.
Plast Reconstr Surg. 2006 Feb;117(2):359-65.
Erbay SH, Bhadelia RA, O'Callaghan M, Gupta P, Riesenburger R, Krackov W, Polak JF.  
Nerve atrophy in severe trigeminal neuralgia: noninvasive confirmation at MR imaging--initial experience.
Radiology. 2006 Feb;238(2):689-92.
Roberge D, Souhami L, Olivier A, Leblanc R, Podgorsak E.  
Hypofractionated Stereotactic Radiotherapy for Low Grade Glioma at McGill University: Long-term Follow-up.
Technol Cancer Res Treat. 2006 Feb;5(1):1-8.
Rossi PJ, Clark PE, Papagikos MA, McCullough DL, Lee WR.  
Percentage of positive biopsies associated with freedom from biochemical recurrence after low-dose-rate prostate brachytherapy alone for clinically localized prostate cancer.
Urology. 2006 Feb;67(2):349-53.